Immunomedics (IMMU) Misses Q4 EPS by 6c
Get Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
Research and development: 14.53M
Today's EPS Names:
DSGN, ATRA, CRVS, More
Financial Fact:
Research and development: 14.53M
Today's EPS Names:
DSGN, ATRA, CRVS, More
Join SI Premium – FREE
Immunomedics (NASDAQ: IMMU) reported Q4 EPS of ($0.17), $0.06 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $900 thousand versus the consensus estimate of $1.2 million.
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Caleres (CAL) Tops Q4 EPS by 1c, Tops on Revenue; Offers Guidance
- Augmedix, Inc. (AUGX) Tops Q4 EPS by 1c
- StoneCo (STNE) Tops Q4 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!